Global Longitudinal Strain Introduction (What it is)
Global Longitudinal Strain is a quantitative measure of how much the left ventricular (LV) myocardium shortens from base to apex during systole.
It is a functional imaging metric most commonly derived from transthoracic echocardiography using speckle-tracking strain analysis.
It complements left ventricular ejection fraction (LVEF) by detecting subtle changes in myocardial performance.
It is widely used in cardiology for risk assessment and longitudinal monitoring in selected diseases and therapies.
Clinical role and significance
Global Longitudinal Strain (often abbreviated GLS) matters because it assesses myocardial deformation, which can change before more familiar measures like LVEF decline. In practical cardiology, this makes GLS valuable for identifying subclinical LV systolic dysfunction—particularly in conditions that preferentially affect the subendocardial longitudinal fibers.
Key clinical roles include:
- Diagnosis and phenotyping: GLS can help characterize patterns of myocardial dysfunction in cardiomyopathies (e.g., infiltrative disease) and in valvular heart disease where systolic performance may appear “preserved” by LVEF.
- Risk stratification: Reduced GLS has been associated in many studies with adverse outcomes across multiple cardiac conditions; however, how GLS is applied to individual decisions varies by clinician and case.
- Treatment monitoring: Serial GLS is commonly discussed in contexts such as potential chemotherapy-related cardiotoxicity and chronic heart failure follow-up, where early functional change may prompt closer surveillance.
- Bridging physiology with clinical imaging: GLS provides a more direct window into myocardial mechanics than simple volumetric change, complementing Doppler indices, chamber sizes, and clinical status.
GLS should be interpreted as part of a full echocardiographic assessment (LV size, wall thickness, diastolic function, right ventricular function, valves, and pulmonary pressures) and within the context of patient symptoms, electrocardiogram (ECG) findings, blood pressure, and comorbidities.
Indications / use cases
Typical scenarios where Global Longitudinal Strain is measured or discussed include:
- Baseline and follow-up assessment in patients receiving potentially cardiotoxic cancer therapies (e.g., anthracyclines or HER2-targeted therapy), where early LV dysfunction is a concern
- Heart failure evaluation, including suspected heart failure with preserved ejection fraction (HFpEF) when systolic function appears “normal” by LVEF
- Cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathy, and suspected infiltrative disease (e.g., cardiac amyloidosis), where strain patterns may support phenotyping
- Valvular heart disease (e.g., aortic stenosis or mitral regurgitation) to detect early LV systolic impairment despite preserved LVEF
- Coronary artery disease evaluation and prior myocardial infarction follow-up, where regional dysfunction can affect global mechanics
- Hypertension and metabolic disease (e.g., diabetes) in selected patients, particularly when subtle LV dysfunction is suspected
- Preoperative or pre-intervention assessment in some patients undergoing major cardiac or non-cardiac surgery, when refined LV functional assessment is desired
Contraindications / limitations
Global Longitudinal Strain is a measurement rather than a therapy, so “contraindications” are best understood as situations where GLS may be unreliable or less suitable than alternative assessments.
Common limitations and situations where another approach may be better include:
- Poor echocardiographic image quality (limited endocardial definition, foreshortened apical views, significant artifact), which impairs tracking accuracy
- Irregular rhythms (notably atrial fibrillation) or frequent ectopy, where beat-to-beat variability complicates consistent strain measurement
- Marked tachycardia or suboptimal frame rate, which can reduce tracking fidelity (requirements vary by device and software)
- Inter-vendor variability (different ultrasound platforms and analysis software), which can affect absolute GLS values and comparability across institutions
- Significant changes in loading conditions (blood pressure, volume status, acute valvular regurgitation), since strain is influenced by afterload and preload
- Conduction abnormalities (e.g., left bundle branch block) and pacing, which can alter contraction patterns and complicate interpretation of global values
- Regional wall motion abnormalities where the global average may obscure clinically important segmental findings unless regional strain is also reviewed
When echocardiography-based GLS is not feasible or is discordant with the clinical picture, alternatives may include careful reassessment of standard echo parameters, cardiac magnetic resonance imaging (CMR), or other modality-based evaluation depending on the question being asked.
How it works (Mechanism / physiology)
Strain describes deformation: the percent change in myocardial length relative to its original length. For LV longitudinal strain, the key concept is the shortening of the ventricle from base to apex during systole. Because the LV shortens in systole, longitudinal strain values are typically negative (shortening is represented as a negative change). In practice, many clinicians focus on the “more negative vs less negative” concept rather than the sign alone:
- More negative GLS generally reflects better longitudinal systolic function.
- Less negative GLS generally reflects impaired longitudinal systolic function.
The physiology is closely tied to myocardial fiber architecture:
- Subendocardial fibers contribute prominently to longitudinal shortening and are often vulnerable to ischemia, fibrosis, and toxic/infiltrative injury.
- Mid-wall and subepicardial fibers contribute more to circumferential shortening and twist, which may help preserve LVEF even when longitudinal function declines early.
GLS is most commonly derived using 2D speckle-tracking echocardiography:
- Natural acoustic markers (“speckles”) within the myocardium are tracked frame-to-frame through the cardiac cycle.
- The software estimates segmental deformation and reports an average value across LV segments (commonly aligned to a standardized segment model).
Onset/duration and reversibility do not apply in the way they do for therapies. Instead, GLS is a snapshot of myocardial mechanics at the time of imaging, and it can change with disease progression, recovery, medical therapy, revascularization, blood pressure changes, and loading conditions.
Global Longitudinal Strain Procedure or application overview
Global Longitudinal Strain is not a procedure; it is an imaging-derived measurement. A typical workflow in clinical practice is:
- Evaluation/exam: A clinician identifies a reason to quantify LV function beyond standard measures (e.g., suspected early cardiomyopathy, therapy monitoring, valvular disease assessment).
- Diagnostics: A transthoracic echocardiogram is performed with particular attention to high-quality apical views (commonly apical 4-chamber, 2-chamber, and long-axis).
- Preparation: Images are acquired with appropriate depth, gain, and frame rate. Avoiding foreshortening of the LV apex is important for accurate longitudinal assessment.
- Intervention/testing: Strain analysis software is used to trace the LV endocardial border and define a region of interest. The software tracks myocardial motion throughout the cardiac cycle and generates segmental and global strain values.
- Immediate checks: The operator reviews tracking quality and adjusts contours if needed. Poorly tracked segments may be excluded depending on lab protocol (varies by device, software, and institution).
- Follow-up/monitoring: Results are interpreted alongside LVEF, LV volumes, wall thickness, diastolic parameters (e.g., transmitral inflow and tissue Doppler), valvular assessment, and clinical context. Serial GLS is most informative when performed with consistent acquisition and analysis methods.
Because GLS values and display formats can differ across platforms, reports often include method details (e.g., vendor/software version) to support longitudinal comparison.
Types / variations
Common variations related to Global Longitudinal Strain include:
- 2D speckle-tracking GLS: The most widely used approach in routine echocardiography labs.
- 3D strain (including 3D GLS): Uses 3D datasets and may reduce some geometric assumptions, but image quality requirements and availability vary by institution.
- Regional longitudinal strain: Segment-by-segment strain values can highlight localized dysfunction (e.g., coronary artery territory involvement) even when the global average is modestly changed.
- Layer-specific strain: Some software reports endocardial vs mid-wall vs epicardial strain, which may be useful in selected research or advanced clinical settings.
- Right ventricular (RV) free-wall strain: Often assessed separately from LV GLS because RV anatomy and loading differ; it is relevant in pulmonary hypertension and right-sided heart failure.
- Left atrial strain: Atrial strain reflects reservoir and conduit function and may be discussed in atrial fibrillation, diastolic dysfunction, and valvular disease; it is distinct from LV GLS.
- Stress echocardiography strain: Strain may be measured during stress protocols in selected centers, though routine use varies by clinician and case.
Advantages and limitations
Advantages:
- Quantifies myocardial function beyond visual assessment and complements LVEF
- Can detect subtle LV systolic impairment when LVEF is still preserved
- Offers a reproducible framework for serial monitoring when methods are consistent
- Provides regional information (segmental strain) alongside a global summary value
- Helps link echocardiographic findings to myocardial mechanics and fiber-level vulnerability
- Can be integrated into a standard transthoracic echocardiogram without additional patient risk
- Useful for communication across multidisciplinary teams when standardized reporting is used
Limitations:
- Dependent on image quality, acquisition technique, and avoidance of LV foreshortening
- Affected by loading conditions (blood pressure, volume status), complicating comparisons across time if physiology changes
- Inter-vendor and inter-software variability can limit direct comparison of absolute values across institutions
- Arrhythmias and frequent ectopy can reduce reliability and increase measurement variability
- Global averaging may obscure clinically important regional abnormalities unless regional strain is reviewed
- Not a stand-alone diagnostic; interpretation requires correlation with symptoms, ECG, biomarkers, and other imaging
- Availability, expertise, and reporting standards vary by lab, device, and institution
Follow-up, monitoring, and outcomes
Monitoring strategies involving Global Longitudinal Strain typically emphasize trend over time rather than a single number. Outcomes and the usefulness of serial GLS are influenced by:
- Baseline cardiac status: Pre-existing coronary artery disease, cardiomyopathy, hypertension-related remodeling, and valvular disease can affect GLS and its trajectory.
- Comorbidities: Diabetes, chronic kidney disease, anemia, and lung disease may influence hemodynamics and myocardial performance.
- Hemodynamic conditions at the time of imaging: Blood pressure, volume status, and acute illness can shift GLS measurements independent of structural progression.
- Consistency of technique: Using the same ultrasound system, analysis software, and acquisition protocol improves comparability for follow-up.
- Co-interpreted echocardiographic parameters: LV volumes, LVEF, diastolic indices, RV function, pulmonary pressures, and valvular lesion severity help contextualize GLS changes.
- Clinical course and therapy: Recovery or deterioration in heart failure, ischemia treatment (e.g., revascularization), and changes in medical therapy may be reflected in GLS, though the relationship varies by clinician and case.
In practice, clinicians often document both the absolute GLS value and the direction of change over time, while acknowledging measurement variability and the influence of loading conditions.
Alternatives / comparisons
Global Longitudinal Strain is one tool among several for assessing cardiac function. Common comparisons include:
- LVEF (2D/3D echocardiography): LVEF is familiar and broadly standardized, but it may remain normal despite early myocardial dysfunction. GLS can add sensitivity to subtle systolic impairment, while LVEF remains essential for many guideline-driven definitions and eligibility decisions.
- Visual wall motion assessment: Quick and useful in acute care (e.g., suspected myocardial infarction), but more subjective and dependent on experience. GLS offers quantification and can support borderline cases, assuming image quality is adequate.
- Tissue Doppler imaging (e.g., mitral annular S’): Provides a measure of longitudinal velocity and is widely available, but it is more angle-dependent and represents a local measurement rather than a global deformation metric.
- Cardiac MRI (CMR): CMR provides high-quality volumes, tissue characterization (e.g., late gadolinium enhancement), and can derive strain (feature tracking). It is often more resource-intensive and less accessible than echocardiography.
- Biomarkers (troponin, natriuretic peptides such as BNP/NT-proBNP): Biomarkers reflect injury and wall stress rather than mechanics. They can complement GLS, particularly in therapy monitoring and heart failure evaluation.
- Nuclear imaging and CT: These can assess perfusion, ischemia, and coronary anatomy; they address different questions than GLS and may be preferred when the primary concern is coronary anatomy or perfusion rather than myocardial mechanics.
The best choice depends on the clinical question (mechanics vs perfusion vs tissue characterization), patient factors, and local expertise and availability.
Global Longitudinal Strain Common questions (FAQ)
Q: Is Global Longitudinal Strain a separate test from an echocardiogram?
It is usually an analysis performed on images from a standard transthoracic echocardiogram. The patient experience is typically the same as a routine echo. Whether it is included depends on lab protocol and the clinical indication.
Q: Does measuring Global Longitudinal Strain hurt or require anesthesia?
No. It is derived from ultrasound images obtained on the chest wall and is noninvasive. Anesthesia and sedation are not part of standard transthoracic strain imaging.
Q: How is Global Longitudinal Strain reported and what does “negative” mean?
GLS is usually reported as a negative percentage because it measures shortening of the LV in systole. More negative values generally indicate better longitudinal systolic function, while less negative values suggest impairment. Exact reference ranges vary by device, software, population, and institution.
Q: How accurate is Global Longitudinal Strain compared with LVEF?
GLS and LVEF measure different aspects of LV function (deformation vs volumetric ejection). GLS can detect subtle dysfunction that may not change LVEF early, but it is more sensitive to image quality and technical factors. Clinicians typically interpret both together rather than replacing one with the other.
Q: Can Global Longitudinal Strain diagnose a specific disease by itself?
Not by itself. Certain strain patterns may support diagnostic considerations (for example, differentiating some cardiomyopathy phenotypes), but GLS must be interpreted with the full echocardiogram, clinical history, ECG, and sometimes additional testing such as CMR or laboratory studies.
Q: How often is Global Longitudinal Strain repeated for monitoring?
Monitoring intervals depend on the clinical scenario, baseline risk, and treatment plan. For example, follow-up practices in cardio-oncology differ from those in valvular heart disease or chronic heart failure. The schedule varies by clinician and case.
Q: How long do Global Longitudinal Strain results “last”?
GLS reflects cardiac mechanics at the time of the study. It can change with blood pressure, volume status, acute illness, ischemia, and longer-term remodeling. For that reason, trends across comparable studies are often more informative than a single measurement.
Q: Is Global Longitudinal Strain considered safe?
Yes, because it uses standard diagnostic ultrasound and does not add invasive risk. The main “risk” is misinterpretation when image quality is poor or when values are compared across different vendors without accounting for variability.
Q: Are there activity restrictions or recovery time after a GLS measurement?
No specific restrictions are typically needed after a standard transthoracic echocardiogram with strain analysis. Patients generally resume usual activities immediately unless they were being evaluated for an acute condition requiring separate precautions.
Q: What determines the cost of Global Longitudinal Strain analysis?
Costs depend on the healthcare system, billing practices, and whether strain analysis is bundled with a standard echocardiogram or billed separately. Coverage and patient responsibility vary by payer, institution, and region.